Supplementary MaterialsSupplementary Information 41467_2019_12628_MOESM1_ESM. ongoing anti-PD-1 efficiency. Thus, our results indicate that sirolimus has the potential to uncouple anti-PD-1 therapy toxicity and efficacy. on the use of mTORi for secondary prevention14. Here, we present a detailed immunophenotyping RTA 402 cell…